In vitro differentiated adipocytes from a Foxc2 reporter knock-in mouse as screening tool

Transgenic Research

Volumn 18, Issue 6, 2009, Pages 889-897

  Cederberg, Anna ^a   Grände, Mats ^a   Rhedin, Magdalena ^b   Peng, Xiao Rong ^b   Enerbäck, Sven ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Assay systems; Genetic engineering; Mouse embryonic fibroblasts; Novel expression systems

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXC2;

ADIPOCYTE; ANIMAL; ANIMAL EMBRYO; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; DRUG SCREENING; FEMALE; FIBROBLAST; GENE TARGETING; GENETICS; LACTOSE OPERON; MALE; METABOLISM; MOLECULAR LIBRARY; MOUSE;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; EMBRYO, MAMMALIAN; FEMALE; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCK-IN TECHNIQUES; LAC OPERON; MALE; MICE; SMALL MOLECULE LIBRARIES;

MUS;

EID: 76049096990     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-009-9280-1     Document Type: Article

References (24)

1. Arner P (2006) Visfatin-a true or false trail to type 2 diabetes mellitus. J Clin Endocrinol Metab 91: 28-30. doi: 10. 1210/jc. 2005-2391.
2. Capecchi MR (2005) Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 6: 507-512. doi: 10. 1038/nrg1619.
3. Carlsson E, Almgren P, Hoffstedt J et al (2004) The FOXC2 C-512T polymorphism is associated with obesity and dyslipidemia. Obes Res 12: 1738-1743. doi: 10. 1038/oby. 2004. 215.
4. Carlsson E, Groop L, Ridderstrale M (2005) Role of the FOXC2-512C>T polymorphism in type 2 diabetes: possible association with the dysmetabolic syndrome. Int J Obes Lond 29: 268-274. doi: 10. 1038/sj. ijo. 0802876.
5. Cederberg A, Gronning LM, Ahren B et al (2001) FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell 106: 563-573. doi: 10. 1016/S0092-8674(01)00474-3.
6. Dagenais SL, Hartsough RL, Erickson RP et al (2004) Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome. Gene Expr Patterns 4: 611-619. doi: 10. 1016/j. modgep. 2004. 07. 004.
7. Di Gregorio GB, Westergren R, Enerback S et al (2004) Expression of FOXC2 in adipose and muscle and its association with whole body insulin sensitivity. Am J Physiol Endocrinol Metab 287: E799-E803. doi: 10. 1152/ajpendo. 00155. 2004.
8. Farmer SR (2003) The forkhead transcription factor Foxo1: a possible link between obesity and insulin resistance. Mol Cell 11: 6-8. doi: 10. 1016/S1097-2765(03)00003-0.
9. Friedrich G, Soriano P (1991) Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5: 1513-1523. doi: 10. 1101/gad. 5. 9. 1513.
10. Gronning LM, Cederberg A, Miura N et al (2002) Insulin and TNF alpha induce expression of the forkhead transcription factor gene Foxc2 in 3T3-L1 adipocytes via PI3K and ERK 1/2-dependent pathways. Mol Endocrinol 16: 873-883. doi: 10. 1210/me. 16. 4. 873.
11. Iida K, Koseki H, Kakinuma H et al (1997) Essential roles of the winged helix transcription factor MFH-1 in aortic arch patterning and skeletogenesis. Development 124: 4627-4638.
12. Jat PS, Noble MD, Ataliotis P et al (1991) Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci USA 88: 5096-5100. doi: 10. 1073/pnas. 88. 12. 5096.
13. Kaestner KH, Bleckmann SC, Monaghan AP et al (1996) Clustered arrangement of winged helix genes fkh-6 and MFH-1: possible implications for mesoderm development. Development 122: 1751-1758.
14. Kovacs P, Lehn-Stefan A, Stumvoll M et al (2003) Genetic variation in the human winged helix/forkhead transcription factor gene FOXC2 in Pima Indians. Diabetes 52: 1292-1295. doi: 10. 2337/diabetes. 52. 5. 1292.
15. Miura N, Wanaka A, Tohyama M et al (1993) MFH-1, a new member of the fork head domain family, is expressed in developing mesenchyme. FEBS Lett 326: 171-176. doi: 10. 1016/0014-5793(93)81785-X.
16. Osawa H, Onuma H, Murakami A et al (2003) Systematic search for single nucleotide polymorphisms in the FOXC2 gene: the absence of evidence for the association of three frequent single nucleotide polymorphisms and four common haplotypes with Japanese type 2 diabetes. Diabetes 52: 562-567. doi: 10. 2337/diabetes. 52. 2. 562.
17. Pressman CL, Chen H, Johnson RL (2000) LMX1B, a LIM homeodomain class transcription factor, is necessary for normal development of multiple tissues in the anterior segment of the murine eye. Genesis 26: 15-25. doi: 10. 1002/(SICI)1526-968X(200001)26: 1<15:: AID-GENE5>3. 0. CO; 2-V.
18. Ridderstrale M, Carlsson E, Klannemark M et al (2002) FOXC2 mRNA Expression and a 5′ untranslated region polymorphism of the gene are associated with insulin resistance. Diabetes 51: 3554-3560. doi: 10. 2337/diabetes. 51. 12. 3554.
19. Smith RS, Zabaleta A, Kume T et al (2000) Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum Mol Genet 9: 1021-1032. doi: 10. 1093/hmg/9. 7. 1021.
20. Winnier GE, Hargett L, Hogan BL (1997) The winged helix transcription factor MFH1 is required for proliferation and patterning of paraxial mesoderm in the mouse embryo. Genes Dev 11: 926-940. doi: 10. 1101/gad. 11. 7. 926.
21. Wolfrum C, Shih DQ, Kuwajima S et al (2003) Role of Foxa-2 in adipocyte metabolism and differentiation. J Clin Invest 112: 345-356.
22. Yanagisawa K, Hingstrup Larsen L, Andersen G et al (2003) The FOXC2-512C>T variant is associated with hypertriglyceridaemia and increased serum C-peptide in Danish Caucasian glucose-tolerant subjects. Diabetologia 46: 1576-1580. doi: 10. 1007/s00125-003-1213-6.
23. Yang X, Enerback S, Smith U (2003) Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes Res 11: 1182-1191. doi: 10. 1038/oby. 2003. 163.
24. Zaman GJ (2004) Cell-based screening. Drug Discov Today 9: 828-830. doi: 10. 1016/S1359-6446(04)03241-6.